WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2003007881) ANTIBODIES SPECIFIC FOR NANOTUBES AND RELATED METHODS AND COMPOSITIONS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2003/007881    International Application No.:    PCT/US2002/022620
Publication Date: 30.01.2003 International Filing Date: 16.07.2002
Chapter 2 Demand Filed:    14.02.2003    
IPC:
A61K 47/48 (2006.01), C07K 16/18 (2006.01), C07K 16/26 (2006.01), C07K 16/44 (2006.01)
Applicants: THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK [US/US]; West 116th Street and Broadway, New York, NY 10027 (US) (For All Designated States Except US).
ERLANGER, Bernard, F. [US/US]; (US) (For US Only).
BRUS, Louis [US/US]; (US) (For US Only).
SHEETZ, Michael, P. [US/US]; (US) (For US Only)
Inventors: ERLANGER, Bernard, F.; (US).
BRUS, Louis; (US).
SHEETZ, Michael, P.; (US)
Agent: WHITE, John, P.; Cooper & Dunham LLP, 1185 Avenue of the Americas, New York, NY 10036 (US)
Priority Data:
60/305,929 16.07.2001 US
60/371,023 08.04.2002 US
Title (EN) ANTIBODIES SPECIFIC FOR NANOTUBES AND RELATED METHODS AND COMPOSITIONS
(FR) ANTICORPS SPECIFIQUES A DES NANOTUBES, AINSI QUE PROCEDES ET COMPOSITIONS ASSOCIES
Abstract: front page image
(EN)This invention provides two compositions. The first composition comprises a nanotube and at least one anti-nanotube antibody, wherein the anti-nanotube antibody is bound to the nanotube. The second composition comprises a fullerene and at least one anti-fullerene antibody, wherein the anti-fullerene antibody is bound to the fullerene. Finally, this invention provides methods and kits relating to the antibody and compositions of matter.
(FR)L'invention concerne deux compositions. La première composition comprend un nanotube et au moins un anticorps anti-nanotube, l'anticorps anti-nanotube étant lié au nanotube. La seconde composition comprend un fullerène et au moins un anticorps anti-fullerène, l'anticorps anti-fullerène étant lié au fullerène. Enfin, l'invention concerne également des procédés et des trousses associés à l'anticorps et aux compositions de l'invention.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, OM, PH, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)